The prepared ODHP-NS-HG reverted the inflammatory effect and suppressed the infection by compromising the levels of COX-2, TNF-α, NF-κB-p105, IL-6, and IL-1β in treated group E comparing to untreated groups. The gene discussed is PTGS2; the disease is infection.